Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2008
11/19/2008EP1991537A2 Novel heterocyclic cycloalkyl derivatives, method for the preparation thereof, and pharmaceutical compositions containing the same
11/19/2008EP1991536A2 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
11/19/2008EP1991533A1 Chemical compounds
11/19/2008EP1991532A2 Compositions and methods for inhibition of the jak pathway
11/19/2008EP1991531A1 Cinnoline and quinoxaline derivates as phosphodiesterase 10 inhibitors
11/19/2008EP1991529A1 Substituted arylsulfonamides as antiviral agents
11/19/2008EP1991527A2 Polymorphous forms of carvedilol phosphate
11/19/2008EP1991526A1 Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (pbr)
11/19/2008EP1991525A1 Cyclohexylamino, benzene, pyridine, and pyridazine derivatives
11/19/2008EP1991523A1 Selective androgen receptor modulators
11/19/2008EP1991516A2 Hydroxylated long-chain resveratrol derivatives useful as neurotrophic agents
11/19/2008EP1991270A2 Compositions and methods for prevention and treatment of cachexia
11/19/2008EP1991248A2 Antidepressant prodrugs
11/19/2008EP1991247A1 Bifunctional histone deacetylase inhibitors
11/19/2008EP1991244A2 Phospholipid complexes of curcumin having improved bioavailability
11/19/2008EP1991243A1 Compositions and methods for increasing adipose metabolism, lipolysis or lipolytic metabolism via thermogenesis
11/19/2008EP1991241A1 Compositions and methods for the induction and maintenance of quality sleep
11/19/2008EP1991239A1 Doxorubicin formulations for anti-cancer use
11/19/2008EP1991238A1 Anti-herpes virus properties of various forms of sophorolipids
11/19/2008EP1991237A2 Chemoprotective methods and compositions
11/19/2008EP1991236A2 Methods of increasing oral bioavailability of tetracyclines
11/19/2008EP1991235A1 Use of 3,5-seco-4-norcholestane derivatives for obtaining a cytoprotective medicament
11/19/2008EP1991234A2 Compositions and methods for the administration psychotropic drugs which modulate body weight
11/19/2008EP1991233A2 Hydroxypiperidine derivatives and uses thereof
11/19/2008EP1991232A1 Combinations of steroids and methylxanthine compounds
11/19/2008EP1991231A1 Methods of treating diseases using inhibitors of nucleoside phosphorylases and nucleosidases
11/19/2008EP1991230A1 Methods of treating cancer
11/19/2008EP1991229A2 Co-crystals and pharmaceutical compositions comprising the same
11/19/2008EP1991228A1 Treatment of prevention of valvular heart disease with flibanserin
11/19/2008EP1991226A2 Inhibitors of histone deacetylase
11/19/2008EP1991225A1 The use of deferiprone and methods to treat and/or prevent friedreich ataxia resulting from intracellular mishandling of iron
11/19/2008EP1991224A2 Use of piperacillin in topical intravaginal preparations for the treatment of vaginal bacterial infections
11/19/2008EP1991223A1 Novel imidazolopyrazole derivatives useful as selective androgen receptor modulators
11/19/2008EP1991222A1 Melatonin and immunostimulating substance-based compositions
11/19/2008EP1991221A2 Methods for increasing blood flow and/or promoting tissue regeneration
11/19/2008EP1991220A1 Heterocyclic compounds and their use in the treatment of cardiovascular disease
11/19/2008EP1991219A2 Stable vitamin c compositions
11/19/2008EP1991218A1 Use of cyclolignans for the treatment of type 2 diabetes and as contraceptives
11/19/2008EP1991217A2 Stearidonic acid for improving cardiovascular health
11/19/2008EP1991216A1 Means and methods for influencing interactions between dc-sign and dc-sign ligands
11/19/2008EP1991215A1 Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases
11/19/2008EP1991214A2 Use of rasagiline for the treatment of multiple system atrophy
11/19/2008EP1991213A2 Anti-mycobacterial formulation comprising octanesulphonylacetamide (osa), nonanesulphonylacetamide (nsa) and decanesulphonylacetamide (dsa)
11/19/2008EP1991212A1 Modulation of neurogenesis by nootropic agents
11/19/2008EP1991211A1 Use of compounds binding to the sigma receptor for the treatment of metabolic syndrome
11/19/2008EP1991207A2 Dosage form and method for the delivery of drugs of abuse
11/19/2008EP1991206A1 Formulations of clopidogrel bisulphate
11/19/2008EP1991202A1 Method for administration tiotropium
11/19/2008EP1991201A1 Nebulised antibiotics for inhalation therapy
11/19/2008EP1991200A2 Fluoroquinolone compositions
11/19/2008EP1991057A2 Nanofluidized b-12 composition and process for treating pernicious anemia
11/19/2008EP1991056A2 Mannose derivatives for killing tumor cells
11/19/2008EP1933856A4 Method for treatment or prevention of conditions caused by gram-positive bacteria
11/19/2008EP1931661B1 Isoxazolo derivatives as gaba a alpha5 inverse agonists
11/19/2008EP1893187B1 Improved antimicrobial peroxidase compositions
11/19/2008EP1853606B1 Pyridopyrazolopyrimidine compounds and their uses as anti-cancer and anti-diabete drugs
11/19/2008EP1845935B1 Use of silymarine and/or the constituents thereof as promoters of the pigmentation of the skin or hair
11/19/2008EP1805201B1 15beta-SUBSTITUTED STEROIDS HAVING SELECTIVE ESTROGENIC ACTIVITY
11/19/2008EP1786434A4 Insecticidal compositions
11/19/2008EP1778861A4 Methods and kits for predicting liver fibrosis progression rate in chronic hepatitis c patients
11/19/2008EP1753727B1 Novel cis-imidazolines
11/19/2008EP1745054B1 Dealkylated derivatives of pyrrolo(2,1-b)benzothiazepines with atypical antipsychotic activity
11/19/2008EP1736157B1 Morphinan derivatives as anti-itching agent
11/19/2008EP1687262B1 Bicyclic amide, carbamate or urea derivatives as vanilloid receptor modulators
11/19/2008EP1677806B1 Methods for treating acute and overuse sprain and strain using hyaluronic acid
11/19/2008EP1675481B1 Synbiotic composition for infants
11/19/2008EP1648484B1 Formulations for the treatment of arhritis conditions
11/19/2008EP1641451B1 Method for photodynamic inactivation of pathogens using ala
11/19/2008EP1613288B1 Solid pharmaceutical compositions comprising a s1p receptor agonist and a sugar alcohol
11/19/2008EP1594862B1 Methods of making 6-[ (4,5-dihydro-1h-imidazol-2-yl)amino-] -7-methyl-1h-benzimidazole-4-carbonitrile and its preferred salt form
11/19/2008EP1542675A4 Compounds useful for the inhibition of aldh
11/19/2008EP1537108B1 Di and trifluoro-triazolo-pyridines anti-inflammatory compounds
11/19/2008EP1532138B1 Inhibitors of tyrosine kinases
11/19/2008EP1509232B1 A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease
11/19/2008EP1478636B1 Amorphous citalopram
11/19/2008EP1470107B1 Fluoro substituted cycloalkanoindoles and their use as prostaglandin d2 receptor antagonists
11/19/2008EP1448545B1 Nf-kb inhibitors
11/19/2008EP1441685B1 Compositions for anti-irritating rosacea treatment
11/19/2008EP1434764B1 Process for obtainment of enantiomers-of n-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide; process for obtainment of non-racemic mixtures between the enantiomers of n-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide; non racemic mixtures of enantiomers of n-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide;pharmaceuticals compositions comprising said non-racemic mixtures of enantiomers of n-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide
11/19/2008EP1427326B1 Combination therapy for the treatment of cancer
11/19/2008EP1417349B1 Novel molecular target for neurotoxicity
11/19/2008EP1372650B1 Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative
11/19/2008EP1349545B1 Pharmaceutical compositions of fenretinide having increased bioavailability and methods of using the same
11/19/2008EP1343529B1 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
11/19/2008EP1320357B1 Topical polymeric antimicrobial emulsion
11/19/2008EP1307226B1 Vitronectin receptor antagonist pharmaceuticals
11/19/2008EP1300158B9 Pharmaceutical compositions for angiogenic therapy
11/19/2008EP1284741B1 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of viral infections
11/19/2008EP1272169B1 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
11/19/2008EP0969844B1 Administration of an injectable antibiotic in the ear of an animal
11/19/2008EP0802921B1 Human pak65
11/19/2008EP0745122B1 Galanin receptor, nucleic acids, transformed cells and uses thereof
11/19/2008CN201150664Y Subcutaneous implantable sustained-release rubber stick for mental disease
11/19/2008CN101309925A Fused tetracyclic mglur1 antagonists as therapeutic agents
11/19/2008CN101309923A N-sulfamoyl-N -benzopyranpiperidines as inhibitors of carbonic anhydrases
11/19/2008CN101309922A Amino-aza-adamantane derivatives and methods of use
11/19/2008CN101309921A Use of pyrrolo[2,3-B]pyridines to prepare a medicament for treating pain
11/19/2008CN101309920A Novel method for producing tiotropium salts
11/19/2008CN101309919A Novel pyrrolidine derivatives as inhibitors of coagulation factor XA
11/19/2008CN101309918A [4-(benzo[b]thiophen-2-yl)-pyrimidin-2-yl]-amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases
1 ... 2990 2991 2992 2993 2994 2995 2996 2997 2998 2999 3000 3001 3002 3003 3004 3005 3006 3007 3008 3009 3010 ... 7860